Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

2025-521620-29-01
Recruiting
Efficacy and safety of two moisturising creams for maintenance treatment of atopic dermatitis
Phase 2 · Norway, Sweden · 11 sites
Registry update: 28 Oct 2026
NCT06827366
Recruiting
Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN)
Not applicable · France · 1 site
Registry update: 5 May 2026
NCT07318129
Recruiting
Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis
Not applicable · Denmark · 1 site
Registry update: 28 Jan 2026
NCT07312942
Recruiting
Effects of Controlled Breathing Added to Therapeutic Exercise in Multiple Myeloma
Not applicable · Spain · 1 site
Registry update: 1 Oct 2026
NCT07233148
Recruiting
Healing ALS Registry Observational Study (HAROS)
Not applicable · United States · 1 site
Registry update: 24 Jun 2026
2023-506826-36-00
Recruiting
A randomized, placebo-controlled, double-blind, 3-period cross-over study in youth with autism spectrum disorders evaluating neural plasticity and learning after a single administration of intranasal oxytocin
Phase 2 · Norway · 1 site
Registry update: 23 Sept 2026
NCT07287917
Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Phase 1/2 · United States · 20 sites
Registry update: 22 Oct 2026
NCT07219212
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 1 · Spain, France, Japan, United States · 25 sites
Registry update: 3 Nov 2026
NCT07853209
Recruiting
A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate Cancer
Phase 3 · South Korea · 8 sites
Registry update: 1 Oct 2026
NCT07402525
Recruiting
Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial
Not applicable · China · 28 sites
Registry update: 11 Feb 2026
NCT07333716
Recruiting
Desloratadine in Patients With Ulcerative Colitis
Phase 2 · Egypt · 1 site
Registry update: 29 Jan 2026
NCT07318259
Recruiting
Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE
Phase 1 · China · 1 site
Registry update: 3 Feb 2026
NCT07835893
Recruiting
Lenvatinib Plus Chemotherapy for pNET Liver Metastases
Phase 2 · China · 1 site
Registry update: 23 Sept 2026
NCT07112599
Recruiting
Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics Analysis
Not applicable · China · 1 site
Registry update: 9 Jan 2026
NCT07373938
Recruiting
Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus
Not applicable · Spain · 1 site
Registry update: 20 Oct 2026
NCT07015190
Recruiting
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Phase 3 · Austria, Australia, Belgium, Canada, Switzerland, Czechia, Germany, Denmark, Estonia, Spain, France, United Kingdom, Greece, Israel, Italy, Netherlands, New Zealand, Poland, Slovenia, Slovakia, United States · 91 sites
Registry update: 6 May 2026
NCT07579234
Recruiting
A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple Myeloma
Phase 3 · China · 1 site
Registry update: 12 May 2026
NCT07319429
Recruiting
Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification
Phase 2/3 · China · 1 site
Registry update: 13 Mar 2026
NCT07409701
Recruiting
Gamification Intervertion in Children With Type 1 Diabetes
Not applicable · 1 site
Registry update: 13 Aug 2026
NCT07299695
Recruiting
Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Phase 3 · Greece · 1 site
Registry update: 16 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.